⚠ Evidence note: Human outcome data on longevity interventions is limited; most claims rest on surrogate markers or animal models. Nothing here is medical advice.
Selenium and Selenoproteins
Current understanding
To be populated as evidence accumulates.
Evidence log
- 2026-09-18 — Selenium Deficiency is a Significant Risk Factor for Sarcopenia: Evidence and Selenoprotein-Mediated Mechanisms.: Systematic review (2024-style narrative synthesis) consolidating epidemiological and clinical association data plus animal-model rescue studies concludes selenium deficiency is a dose-responsive risk factor for sarcopenia, with mechanistic mapping to GPX4 (ferroptosis defense), SELENOP (Se transport), SELENOW (redox in muscle), and SELENOT/N (ER Ca²⁺ and regeneration) — evidence remains observational + preclinical, no sarcopenia-endpoint RCT of Se supplementation. [human-observational] (novelty: 3)
Open questions
Related
Contributing findings
Selenium Deficiency is a Significant Risk Factor for Sarcopenia: Evidence and Selenoprotein-Mediated Mechanisms.
18-sep-2026
novelty 3
per-area 3
strengthens
Iron metabolism and ferroptosis in cardiovascular diseases: progress in the mechanism and pharmacological intervention.
29-jul-2026
novelty 2
per-area 1
mentions